Trinacrene (1) is a promising—and very attractive-new cage compound with a name derived from an old designation for Sicily (Trinacrien). The synthesis of 1 was accomplished in two steps involving six (2 × 3) Diels–Alder reactions and highly symmetrical precursors, the second step being a high-pressure reaction (10 kbar). Compound 1 displays D3h symmetry and gives only the predicted five 1H NMR signals.
No takes yet. Share an insight, caveat, or question.
Ashton et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: